SPRY logo
SPRY NASDAQ US

ARS Pharmaceuticals, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Dec 2020
$8.30
▲ +$0.19 (+2.34%)
Vol 1.3M
4
Quality Score
fail
Mkt Cap
$1.2B
ROE
-38.8%
Margin
-56.1%
D/E
65.17
Beta
0.82
52W
$7–$19

Wall Street Consensus

12 analysts · Apr 2026
6
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
91.7%
Buy Rating

Price Chart

Similar Stocks

XNCR
Xencor Inc
$1.1B
ABUS
Arbutus Biopharma Corp
$925.1M
CGEM
Cullinan Therapeutics Inc
$611.4M
SANA
Sana Biotechnology Inc
$1.1B
ANNX
Annexon Inc
$726.5M
MNKD
MannKind Corp
P/E 60.5
$1.7B
JBIO
Jade Biosciences Inc
$709.8M
KURA
Kura Oncology Inc
$904.1M

Earnings

Beat rate: 75.0%
Next Report May 12, 2026
EPS Estimate: $-0.51
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.51 — —
Dec 2025 $-0.45 $-0.42 +$0.03
Sep 2025 $-0.48 $-0.52 $-0.04
Jun 2025 $-0.48 $-0.46 +$0.02

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -21.9% -21.9% -21.9% -21.9% -38.8% -38.8%
P/E (TTM) — — — — — —
Net Margin -285.6% -42.7% -42.7% -42.7% -56.1% -56.1%
Gross Margin 68.3% 93.7% 93.7% 93.7% 89.4% 89.4%
D/E Ratio 0.00 0.00 0.00 0.00 65.17 65.17
Current Ratio 6.17 6.17 6.17 6.17 6.66 6.66

Key Ratios

ROA (TTM)
-23.5%
P/S (TTM)
8.07
P/B
4.0
EPS (TTM)
$-0.90
CF/Share
$-0.24
52W High
$18.90
52W Low
$6.66
$6.66 52-Week Range $18.90

How does SPRY compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

SPRY AAPG ABEO ABOS ABP

SPRY valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
8.1
▼ 37% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
4.0
▲ 62% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

SPRY profitability vs Biotechnology peers

ROE
-38.8%
▲ 42% above peers (-67.3%)
vs Peers
vs Industry
Below avg
Net margin
-56.1%
▲ 80% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
89.4%
▲ 14% above peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-23.5%
▲ 50% above peers (-46.7%)
vs Peers
vs Industry
Top tier

SPRY financial health vs Biotechnology peers

D/E ratio
65.2
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
6.7
▲ 50% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
0.8
▼ 16% below peers (1.0)
vs Peers
vs Industry
More volatile

SPRY fundamentals radar

SPRY Peer median Industry

SPRY profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

SPRY vs peers: key metrics

Latest News

No related news yet